Profile data is unavailable for this security.
About the company
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
- Revenue in USD (TTM)0.00
- Net income in USD-34.17m
- Incorporated2008
- Employees69.00
- LocationPolyPid Ltd18 Hasivim Street,P.O Box 7126PETAH TIKVA 4917002IsraelISR
- Websitehttps://www.polypid.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LifeVantage Corp | 210.05m | 7.86m | 57.83m | 232.00 | 7.54 | 1.75 | 5.37 | 0.2753 | 0.5998 | 0.5998 | 16.16 | 2.58 | 3.24 | 2.45 | 96.73 | 905,370.70 | 12.12 | 9.17 | 18.91 | 14.08 | 78.75 | 80.73 | 3.74 | 2.93 | 1.03 | -- | 0.00 | 35.06 | 14.17 | -0.3794 | 233.84 | -3.22 | -12.55 | -- |
| ImmuCell Corp | 27.77m | 2.32m | 59.16m | 70.00 | 25.27 | 1.99 | 11.78 | 2.13 | 0.2588 | 0.2588 | 3.09 | 3.29 | 0.6159 | 1.90 | 11.42 | 402,453.60 | 5.15 | -5.35 | 5.69 | -5.77 | 40.93 | 36.02 | 8.37 | -11.87 | 1.76 | 6.47 | 0.2415 | -- | 51.64 | 14.06 | 62.65 | -- | -19.66 | -- |
| Janel Corp | 212.13m | 5.02m | 61.37m | 353.00 | 12.42 | 2.60 | 6.94 | 0.2893 | 4.17 | 4.17 | 175.99 | 19.89 | 1.48 | 32.91 | 3.83 | 600,929.20 | 3.97 | 1.76 | 13.95 | 5.33 | 32.04 | 26.69 | 2.69 | 0.9608 | 0.7095 | 3.62 | 0.5020 | 0.00 | 13.24 | 20.27 | 2,155.61 | -- | -14.58 | -- |
| Scilex Holding Co | 40.36m | -375.84m | 68.69m | 30.00 | -- | -- | -- | 1.70 | -33.18 | -33.18 | 4.08 | -28.88 | 0.2145 | 7.27 | 1.85 | 350,956.50 | -177.73 | -- | -- | -- | 68.59 | 75.06 | -828.56 | -176.54 | 0.0429 | -3.76 | -- | -- | 21.07 | 21.89 | 56.40 | -- | -49.14 | -- |
| Cumberland Pharmaceuticals, Inc. | 41.28m | -3.33m | 72.39m | 91.00 | -- | 2.77 | 57.36 | 1.75 | -0.2331 | -0.2331 | 2.79 | 1.75 | 0.5788 | 1.72 | 3.80 | 453,608.30 | -4.68 | -6.88 | -7.60 | -9.65 | 84.49 | 80.74 | -8.09 | -15.89 | 1.11 | -28.41 | 0.1688 | -- | -4.26 | 1.95 | -3.19 | -- | -29.32 | -- |
| Rafael Holdings Inc | 1.03m | -31.33m | 75.06m | 21.00 | -- | 0.8917 | -- | 72.94 | -0.8471 | -0.8471 | 0.0284 | 1.63 | 0.0107 | -- | 3.35 | 49,000.00 | -32.33 | -45.03 | -37.62 | -51.75 | 89.70 | -- | -3,034.89 | -8,772.74 | 3.98 | -- | 0.0074 | -- | 43.96 | -28.51 | 11.30 | -- | -47.65 | -- |
| Assertio Holdings Inc | 137.35m | -28.92m | 75.53m | 58.00 | -- | 0.7138 | 34.22 | 0.5499 | -4.71 | -4.71 | 20.93 | 16.49 | 0.4611 | 1.35 | 1.47 | 2,368,138.00 | -9.71 | -15.74 | -17.07 | -24.19 | 68.16 | 82.29 | -21.06 | -42.01 | 1.43 | -- | 0.2702 | -- | -17.83 | -11.45 | 93.50 | -- | -- | -- |
| Pliant Therapeutics Inc | 0.00 | -175.50m | 78.04m | 171.00 | -- | 0.3896 | -- | -- | -2.87 | -2.87 | 0.00 | 3.26 | 0.00 | -- | -- | 0.00 | -48.60 | -38.70 | -52.81 | -41.26 | -- | -- | -- | -1,044.87 | -- | -- | 0.1319 | -- | -100.00 | -- | -30.35 | -- | 31.90 | -- |
| Pelthos Therapeutics Inc | 7.41m | -23.58m | 78.17m | 4.00 | -- | 1.28 | -- | 10.56 | -17.09 | -17.09 | 6.02 | 18.85 | 0.1152 | -- | -- | 1,851,500.00 | -36.68 | -- | -47.05 | -- | 68.73 | -- | -318.41 | -- | 1.04 | -12.32 | 0.00 | -- | -- | -- | -7.78 | -- | -- | -- |
| Polypid Ltd | 0.00 | -34.17m | 82.82m | 69.00 | -- | 7.20 | -- | -- | -2.26 | -2.26 | 0.00 | 0.6028 | 0.00 | -- | -- | 0.00 | -143.79 | -105.84 | -252.10 | -143.44 | -- | -- | -- | -- | 1.82 | -27.54 | 0.0826 | -- | -- | -- | -17.73 | -- | -23.10 | -- |
| Verrica Pharmaceuticals Inc | 30.83m | -26.01m | 85.87m | 71.00 | -- | -- | -- | 2.79 | -3.44 | -3.44 | 3.50 | -1.80 | 0.8352 | 1.09 | 8.75 | 434,211.30 | -70.48 | -71.91 | -217.79 | -111.91 | 91.36 | -- | -84.38 | -729.00 | 1.18 | -1.70 | 1.94 | -- | 47.66 | -- | -14.31 | -- | -47.58 | -- |
| Biostem Technologies Inc | 235.17m | 20.20m | 93.15m | 67.00 | 6.15 | 1.86 | 4.56 | 0.3961 | 0.9019 | 0.9019 | 11.60 | 2.98 | 2.82 | 2.61 | 4.65 | -- | 24.25 | -- | 55.07 | -- | 97.33 | -- | 8.59 | -- | 4.09 | -- | 0.0566 | -- | 1,708.93 | -- | 475.86 | -- | -- | -- |
| Fortress Biotech Inc | 62.30m | -5.34m | 102.43m | 101.00 | -- | 1.83 | -- | 1.64 | -0.293 | -0.293 | 2.16 | 1.80 | 0.4039 | 1.50 | 4.35 | 616,861.40 | -34.90 | -54.95 | -51.59 | -102.13 | 71.56 | 62.39 | -86.41 | -227.71 | 1.97 | -10.63 | 0.4503 | -- | -31.76 | 9.50 | 18.61 | -- | 25.88 | -- |
Data as of Mar 03 2026. Currency figures normalised to PolyPid Ltd's reporting currency: US Dollar USD
28.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AIGH Capital Management LLCas of 31 Dec 2025 | 1.34m | 13.18% |
| Rosalind Advisors, Inc.as of 31 Dec 2025 | 696.56k | 6.84% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 208.12k | 2.04% |
| DAFNA Capital Management LLCas of 31 Dec 2025 | 207.90k | 2.04% |
| J. Goldman & Co. LPas of 31 Dec 2025 | 172.31k | 1.69% |
| Symmetry Peak Management LLCas of 31 Dec 2025 | 127.33k | 1.25% |
| Adar1 Capital Management LLCas of 31 Dec 2025 | 103.95k | 1.02% |
| Lumbard & Kellner LLCas of 31 Dec 2025 | 38.20k | 0.38% |
| XTX Markets LLCas of 31 Dec 2025 | 32.66k | 0.32% |
| Jane Street Capital LLCas of 31 Dec 2025 | 15.20k | 0.15% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
